Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Napoli

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Diabetes Research and Clinical Practice|October 1, 2020
Titratable fixed-ratio combination of insulin glargine plus lixisenatide: A simplified approach to glycemic control in type 2 diabetes mellitusFrancesco Giorgino, Irene Caruso, Raffaele Napoli
Clinical Endocrinology|February 21, 2004
Growth hormone, acromegaly, and heart failure: an intricate triangulationLuigi Saccà, Raffaele Napoli, Antonio Cittadini
Heart Failure Clinics|November 19, 2019
Anabolic Deficiencies in Heart Failure: Ready for Prime Time?Raffaele Napoli, Roberta D'Assante, Martina Miniero, et al.
Cardiology Clinics|April 25, 2022
Anabolic Deficiencies in Heart Failure: Ready for Prime Time?Raffaele Napoli, Roberta D'Assante, Martina Miniero, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world studyRaffaele Napoli, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 7, 2023
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world studyRiccardo Candido, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 1, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world studyRiccardo Candido, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT studyRaffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2020
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes SocietyRaffaele Napoli, Gloria Formoso, Salvatore Piro, et al.
Case Reports in Vascular Medicine|November 6, 2013
A giant pseudoaneurysm of the forearm as unusual complication of bacterial endocarditisMichele Arcopinto, Teresa Russo, Antonio Ruvolo, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Diabetes Research and Clinical Practice|October 1, 2020
Titratable fixed-ratio combination of insulin glargine plus lixisenatide: A simplified approach to glycemic control in type 2 diabetes mellitusFrancesco Giorgino, Irene Caruso, Raffaele Napoli
Clinical Endocrinology|February 21, 2004
Growth hormone, acromegaly, and heart failure: an intricate triangulationLuigi Saccà, Raffaele Napoli, Antonio Cittadini
Heart Failure Clinics|November 19, 2019
Anabolic Deficiencies in Heart Failure: Ready for Prime Time?Raffaele Napoli, Roberta D'Assante, Martina Miniero, et al.
Cardiology Clinics|April 25, 2022
Anabolic Deficiencies in Heart Failure: Ready for Prime Time?Raffaele Napoli, Roberta D'Assante, Martina Miniero, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world studyRaffaele Napoli, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 7, 2023
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world studyRiccardo Candido, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 1, 2024
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world studyRiccardo Candido, Antonio Nicolucci, Monica Larosa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT studyRaffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2020
Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes SocietyRaffaele Napoli, Gloria Formoso, Salvatore Piro, et al.
Case Reports in Vascular Medicine|November 6, 2013
A giant pseudoaneurysm of the forearm as unusual complication of bacterial endocarditisMichele Arcopinto, Teresa Russo, Antonio Ruvolo, et al.
Pageof 6